These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22877422)

  • 21. Chemotherapy for advanced non-small cell lung cancer in the elderly population.
    Santos FN; Castria TB; Cruz MR; Riera R
    Sao Paulo Med J; 2016; 134(5):465-466. PubMed ID: 27901246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoadjuvant chemotherapy in early-stage non-small cell lung cancer.
    Edelman MJ
    Expert Rev Anticancer Ther; 2001 Aug; 1(2):229-35. PubMed ID: 12113028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neoadjuvant chemotherapy in the treatment of nonsmall-cell lung cancer.
    De Pauw R; van Meerbeeck JP
    Curr Opin Oncol; 2007 Mar; 19(2):92-7. PubMed ID: 17272979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlates of benefit from neoadjuvant chemotherapy before radiotherapy in non-small cell lung cancer: a meta-analytical approach with meta-regression analysis.
    Bozcuk H; Artac M; Ozdogan M
    J BUON; 2010; 15(1):43-50. PubMed ID: 20414926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is There a Survival Benefit in Patients With Stage IIIA (N2) Non-small Cell Lung Cancer Receiving Neoadjuvant Chemotherapy and/or Radiotherapy Prior to Surgical Resection: A Systematic Review and Meta-analysis.
    Xu YP; Li B; Xu XL; Mao WM
    Medicine (Baltimore); 2015 Jun; 94(23):e879. PubMed ID: 26061306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neoadjuvant chemotherapy in non small cell lung cancer].
    Besse B; Vignot S; Le Chevalier T
    Bull Cancer; 2006 Nov; 93(11):1087-92. PubMed ID: 17145577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of mediastinal lymph node status and relapse pattern in clinical stage IIIA non-small cell lung cancer patients treated with neoadjuvant chemotherapy versus upfront surgery: A single center experience.
    Savic M; Kontic M; Ercegovac M; Stojsic J; Bascarevic S; Moskovljevic D; Kostic M; Vesovic R; Popevic S; Laban M; Markovic J; Jovanovic D
    Thorac Cancer; 2017 Sep; 8(5):393-401. PubMed ID: 28671758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
    Evans WK; Kocha W; Gagliardi A; Eady A; Newman TE
    Cancer Prev Control; 1999 Feb; 3(1):84-94. PubMed ID: 10474757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Accuracy of Clinical Staging of Stage I-IIIa Non-Small Cell Lung Cancer: An Analysis Based on Individual Participant Data.
    Navani N; Fisher DJ; Tierney JF; Stephens RJ; Burdett S;
    Chest; 2019 Mar; 155(3):502-509. PubMed ID: 30391190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant and neoadjuvant chemotherapy in NSCLC: a paradigm shift.
    Betticher DC
    Lung Cancer; 2005 Dec; 50 Suppl 2():S9-16. PubMed ID: 16557669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy in stage I+II non-small cell lung cancer.
    Ukena D
    Lung Cancer; 2001 Sep; 33 Suppl 1():S25-8. PubMed ID: 11576704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of neoadjuvant chemotherapy on the survival outcomes of patients with resectable non-small-cell lung cancer: A meta-analysis of randomized controlled trials.
    Zhang Y; Hu X; Liu D; Wang R; Sun X; Peng Z; Ren H; Du N
    Surg Oncol; 2021 Sep; 38():101590. PubMed ID: 34091269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survivin mRNA Level in Blood Predict the Efficacy of Neoadjuvant Chemotherapy in Patients with Stage IIIA-N2 Non-Small Cell Lung Cancer.
    Hu YM; Li J; Yu LC; Shi SB; Du YJ; Wu JN; Shi WL
    Pathol Oncol Res; 2015 Apr; 21(2):257-65. PubMed ID: 24980156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of neoadjuvant chemotherapy in NSCLC.
    Tonato M
    Chest; 1996 May; 109(5 Suppl):93S-95S. PubMed ID: 8635396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neoadjuvant treatment of early-stage resectable non-small-cell lung cancer.
    Betticher DC; Rosell R
    Lung Cancer; 2004 Dec; 46 Suppl 2():S23-32. PubMed ID: 15698528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neoadjuvant chemotherapy and chemoradiotherapy for non-small cell lung cancer: current status and future prospects.
    Edelman MJ
    Expert Opin Pharmacother; 2003 Jun; 4(6):843-52. PubMed ID: 12783581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term effects of neoadjuvant radiotherapy, adjuvant radiotherapy, and chemotherapy-only on survival of locally advanced non-small cell lung Cancer undergoing surgery: a propensity-matched analysis.
    Wang X; Yin C; Su S; Li X; Wang C; Zhang C; Liu M
    BMC Cancer; 2018 Nov; 18(1):1067. PubMed ID: 30400782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elemene injection as adjunctive treatment to platinum-based chemotherapy in patients with stage III/IV non-small cell lung cancer: A meta-analysis following the PRISMA guidelines.
    Wang X; Liu Z; Sui X; Wu Q; Wang J; Xu C
    Phytomedicine; 2019 Jun; 59():152787. PubMed ID: 31005810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoadjuvant Chemoradiation Shows No Survival Advantage to Chemotherapy Alone in Stage IIIA Patients.
    Krantz SB; Mitzman B; Lutfi W; Kuchta K; Wang CH; Howington JA; Kim KW
    Ann Thorac Surg; 2018 Apr; 105(4):1008-1016. PubMed ID: 29453000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the efficacy and safety of single-agent erlotinib and doublet molecular targeted agents based on erlotinib in advanced non-small cell lung cancer (NSCLC): a systematic review and meta-analysis.
    Pan G; Ke S; Zhao J
    Target Oncol; 2013 Jun; 8(2):107-16. PubMed ID: 23516098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.